{"id":"W4388824122","doi":"10.21203/rs.3.rs-3611288/v1","title":"Brain volume loss in relapsing multiple sclerosis: Indirect treatment comparisons of available disease-modifying therapies","year":2023,"lang":"en","type":"preprint","venue":"Research Square","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"EVERSANA (Canada); Ottawa Hospital","funders":"Janssen Pharmaceuticals; Bristol-Myers Squibb","keywords":"Medicine; Fingolimod; Teriflunomide; Internal medicine; Confidence interval; Meta-analysis; Placebo; Randomized controlled trial; Clinical trial; Clinical endpoint; Confounding; Multiple sclerosis; Pathology; Immunology; Alternative medicine","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.03064164,0.00297338,0.01463275,0.003920603,0.000430601,0.003547245,0.00180728,0.002026291,0.004233151],"category_scores_gemma":[0.04747242,0.001092217,0.03980105,0.003297857,0.001140774,0.001736128,0.002151579,0.003156576,0.0003175391],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00142524,"about_ca_system_score_gemma":0.001361272,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002154638,"about_ca_topic_score_gemma":0.002736873,"domain_scores_codex":[0.9532903,0.03742826,0.004227284,0.00273893,0.001997792,0.0003173342],"domain_scores_gemma":[0.9516906,0.04059266,0.004533924,0.00148943,0.00135051,0.000342856],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","study_design_scores_codex":[0.0116087,0.00008466589,0.002327576,0.05994577,0.9158707,0.00005703563,0.0000593329,0.001178583,0.000294442,0.0003694427,0.0002273699,0.00797636],"study_design_scores_gemma":[0.006413251,0.002030953,0.004176594,0.004389308,0.9788923,0.00007766764,0.00005129412,0.001012188,0.0003464204,0.001220546,0.001350251,0.00003915473],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","genre_codex":"review","genre_gemma":"empirical","genre_scores_codex":[0.06127257,0.9251109,0.00649421,0.0008584216,0.001194115,0.001084469,0.002185444,0.0001017587,0.001698023],"genre_scores_gemma":[0.8849342,0.1003685,0.008108732,0.001356939,0.0005493994,0.00225198,0.00164518,0.00005507849,0.0007300466],"genre_candidate":"empirical","genre_consensus":null,"teacher_disagreement_score":0.03064164,"threshold_uncertainty_score":0.1620504,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.3639352883894827,"score_gpt":0.425879992181911,"score_spread":0.06194470379242828,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}